Anti-adhesion flusher for pleuroperitoneal cavity

Abstract

The invention discloses an anti-adhesion flusher for a pleuroperitoneal cavity. The anti-adhesion flusher for the pleuroperitoneal cavity can be used for conducting anti-adhesion pleuroperitoneal cavity washing. The anti-adhesion flusher for the pleuroperitoneal cavity is composed of a metal puncture needle, a main part of a Y-shaped hard paper tube and two branches of the Y-shaped hard paper tube, wherein the metal puncture needle is connected with the main part of the Y-shaped hard paper tube, one branch of the Y-shaped hard paper tube is connected with an injection syringe for sucking liquid, and the other branch of the Y-shaped hard paper tube is connected with the injection syringe for injecting perflurocarbon liquids. A doctor sucks hydrothorax and ascite through the injection syringe, a rubber plug is covered, the perflurocarbon liquids are injected, the rubber plug is covered, the process is conducted repeatedly, and flushing is carried out until no cellulose flows out.

Description

Technical field [0001] The invention relates to a device for doctors in a hospital to perform thoracoperitoneal cavity anti-adhesion flushing on patients. Background technique [0002] At present, the known device for pleuraperitoneal flushing mainly injects cellulose-dissolving drugs such as urokinase into the thoracic peritoneal cavity, dissolves the adherent fibers, rinses with normal saline, and then passes through a drainage tube placed in the pleural peritoneal cavity. Drain slowly. This method has the following problems: 1. Fibrinolytic drugs such as urokinase are easy to cause bleeding, and cannot be used for all patients with thoracic peritonitis; 2. These fibrinolytic drugs cannot be used as fibrinolytic drugs when there are no fibrous adhesions due to certain toxic and side effects. Preventive medication; 3. The drainage speed of the thoracoperitoneal cavity drainage tube is slow, which leads to the precipitation of cellulose and other proteins in the pleural per...

AI Technical Summary

Problems solved by technology

This method has the following problems: 1. Fibrinolytic drugs such as urokinase are easy to cause bleeding, and cannot be used for all patients with thoracic peritonitis; 2. These fibrinolytic drugs cannot be used as fibrinolytic drugs when there are no fibrous adhesions due to certain toxic and side effects. Preventive medication; 3. The drainage speed of the thoracoperitoneal cavity drainage tube is slow, resulting in the precipitation of cellulose and other proteins in the pleural peritoneal cavity fluid, and even blocking the drainage tube. It is difficult to drain out in the later stage, and it cannot be drained clean

And because the drainage is slow and takes too long, it increases the chance of infection

Even if a syringe is used for suction, since the syringe and the puncture needle are connected by a soft rubber tube, during the suction process, the rubber tube often collapses and occludes due to uneven internal pressure, making the process of pumping pleural and peritoneal effusion laborious time consuming

Images